New draft guidance published by NICE – the National Institute for Health and Care Excellence recommends the use of the digital technology ‘QbTest’ to help diagnose ADHD in children and young people. 

QbTest is a technology that supports objective assessment within the ADHD diagnosis pathway, helping to supplement clinical judgement by measuring a patient’s attention, impulsivity, and motor activity – the three are core symptoms of ADHD. 

Developed by company Qbtech, the technology has been rolled out across England from 2020 as part of our Focus ADHD national programme, led by the 15 local networks. 

A total of 79 NHS trusts have adopted the technology since 2020 – around three quarters of all trusts that provide ADHD diagnosis – benefiting more than 70,000 young people. 

Evaluation of the technology within the East Midlands showed it can help speed up the time from assessment to diagnosis reduced by an average of 153 days.  

This increases staff capacity by reducing the number of appointments needed for diagnosis, and since April 2020 an estimated 20,439 NHS appointments have been freed up across England. 

This has saved the NHS an estimated £24m, enabling redirection of resources to other parts of the ADHD care pathway, and is a great example of local change having a national impact. 

NICE’s draft guidelines on the diagnosis and management of ADHD were published on 16 July; a consultation is underway and comments can be submitted up to 6 August 2024. 

Find out more about the Health Innovation Network’s Focus ADHD national programme and meet Tony Doyle, Managing Director of Qbtech in our ‘Meet the Innovator’ interview. 

  • The role innovation plays in reducing demand through delivering a Net Zero NHS

    Pete Waddingham, the Health Innovation Network's Net Zero Lead, discusses how we're supporting a Net Zero NHS through innovation, and its potential to reduce demand.  We all know climate change contributes to poor health, with air pollution linked to a number of health conditions including cardiovascular disease, respiratory disease and cancer. We also know it’s [...]

  • Meet the innovator: Karina Malhotra, Acumentice

    Karina Malhotra (pictured on the right) is the Founder and Managing Director of Acumentice - a healthcare improvement consultancy. Karina’s background is in the NHS, with operational leadership roles in NHS Trusts across London. Her product, Evolve Learning, provides targeted learning and development for staff in the NHS. It’s delivered on an e-learning platform, in [...]

  • Improving health and wealth: how innovation contributes to economic growth

    At the Health Innovation Network we have always had a dual focus on improving both the health and wealth of the nation and have demonstrated the huge contribution that the health and life sciences industry can make to economic growth. Since 2018, our support to innovators has leveraged £2.6 billion for the UK economy.  We're [...]